US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Adia Nutrition, Inc.

0.1850

-0.0150-7.50%

Volume:47.71K

Turnover:10.15K

Market Cap:17.46M

PE:-93.77

High:0.2250

Open:0.2250

Low:0.1850

Close:0.2000

52wk High:0.2777

52wk Low:0.0125

Shares:94.40M

Float Shares:94.40M

Volume Ratio:0.43

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0020

EPS(LYR):0.0000

ROE:-1460.81%

ROA:-32.76%

PB:-180.86

PE(LYR):-23,125.00

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Adia Nutrition Names Dr. Brian Browning Lead Physician for Orthopedic Treatments

Foreign Capital Is Returning to Hong Kong Stocks in a Big Way

Adia Nutrition Promotes Emmanuela Derisbrun to Provider Role

Adia Nutrition Names Dawn Bell Chief Revenue Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADIA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIA\",,,,,undefined,":{"symbol":"ADIA","market":"US","secType":"STK","nameCN":"Adia Nutrition, Inc.","latestPrice":0.185,"timestamp":1770411600000,"preClose":0.2,"halted":0,"volume":47705,"delay":15,"changeRate":-0.07500000000000007,"floatShares":94404700,"shares":94404700,"eps":-0.001973,"marketStatus":"Market Closed","change":-0.015,"latestTime":"02-06 16:00:00 EST Delay","open":0.225,"high":0.225,"low":0.185,"amount":10151.3,"amplitude":0.2,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.001973,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.2,"volumeRatio":0.430617},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIA\",,,,,undefined,":{"symbol":"ADIA","floatShares":94404700,"roa":"-32.76%","roe":"-1460.81%","lyrEps":-0.000008,"volumeRatio":0.430617,"shares":94404700,"dividePrice":0,"high":0.225,"amplitude":0.2,"preClose":0.2,"low":0.185,"week52Low":0.0125,"pbRate":"-180.86","psRate":"2737.44","week52High":0.27767,"institutionHeld":0,"latestPrice":0.185,"eps":-0.001973,"divideRate":0,"volume":47705,"delay":15,"ttmEps":-0.001973,"open":0.225,"prevYearClose":0.078,"prevWeekClose":0.2346,"prevMonthClose":0.2346,"prevQuarterClose":0.078},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADIA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608862195","title":"Adia Nutrition Names Dr. Brian Browning Lead Physician for Orthopedic Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2608862195","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608862195?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:02","pubTimestamp":1770040935,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on February 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL4Kd5mZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"1150603542","title":"Foreign Capital Is Returning to Hong Kong Stocks in a Big Way","url":"https://stock-news.laohu8.com/highlight/detail?id=1150603542","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150603542?lang=en_us&edition=fundamental","pubTime":"2026-01-18 21:41","pubTimestamp":1768743713,"startTime":"0","endTime":"0","summary":"Mainstream international long-only funds have returned to participating in equity financing and issuance projects for Chinese companies. Goldman Sachs recently noted that the participation rate of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIA","BK4183"],"gpt_icon":0},{"id":"2603981274","title":"Adia Nutrition Promotes Emmanuela Derisbrun to Provider Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2603981274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603981274?lang=en_us&edition=fundamental","pubTime":"2026-01-16 00:04","pubTimestamp":1768493061,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has promoted Emmanuela Derisbrun, APRN, FNP-C, from subcontractor to employed provider at its medical division, Adia Med, to support growing patient demand and the launch of its autism spectrum disorder regenerative study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on January 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL2V4T7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0},{"id":"2601536215","title":"Adia Nutrition Names Dawn Bell Chief Revenue Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536215","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536215?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:31","pubTimestamp":1767879084,"startTime":"0","endTime":"0","summary":"Adia Nutrition Inc. has appointed Dawn Bell as Chief Revenue Officer through its subsidiary, ADIA Labs. Bell brings over 15 years of experience in sales strategy within the medical device and pharmaceutical sectors. She will focus on driving growth and supporting physicians and clinics in integrating ADIA's regenerative therapies and diagnostic services.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile  on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLpSPc2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ADIA\",params:#limit:6,delay:false,,,undefined,":[]}}